Gilead up in premarket as it says it's presented new remdesivir data
Shares of Gilead Sciences Inc.
gained 2.0% in premarket trading on Friday after the drugmaker disclosed findings from a new analysis of previously disclosed clinical trial data that found the experimental therapy remdesivir can reduce the risk of mortality in COVID-19 patients by 62%, when compared to the standard of care. Gilead said the mortality data point is"an important finding that requires confirmation in prospective clinical trials.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Gilead Testing Inhaled Form Of Remdesivir That Could Be Used To Treat Covid-19 Outside HospitalGilead is launching a phase 1 clinical trial of an inhaled version of remdesivir, a drug used to treat Covid-19, that could be administered to patients outside of the hospital
Read more »
Gilead begins testing inhalable form of remdesivir for COVID-19Gilead Sciences Inc said on Wednesday it has started an early-stage study of its antiviral COVID-19 treatment remdesivir that can be inhaled, for use outside of hospitals.
Read more »
Gilead says remdesivir coronavirus treatment reduces risk of death
Read more »
‘Shocked and Appalled’ Boohoo Sees Shares Plummet, Despite ChangesThe embattled online retailer has cut ties with two suppliers already and said it will conduct an independent review into its supply chain, but that was not enough to stem the bleeding on London&8…
Read more »
Bully Shares Video for New Single 'Every Tradition'.Bully shares video for new single, 'Every Tradition,' taken from their forthcoming album 'SUGAREGG':
Read more »
Gisele Bündchen Shares Cute Yoga Transformation Photos With 'Mini Me' Daughter Vivian'My little yoga partner is growing so fast! 2013-> 2020.'
Read more »